• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种辉瑞-生物科技公司新冠疫苗后发生急性肾损伤的微小病变型肾病综合征

Minimal Change Nephrotic Syndrome with Acute Kidney Injury after the Administration of Pfizer-BioNTech COVID-19 Vaccine.

作者信息

Gulumsek Erdinc, Ozturk Dilan Damla, Ozturk Huseyin Ali, Saler Tayyibe, Erdogan Kivilcim Eren, Bashir Ahmed Muhammad, Sumbul Hilmi Erdem

机构信息

Department of Gastroenterology, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

Department of Internal Medicine, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.

出版信息

Case Rep Infect Dis. 2023 Feb 22;2023:5122228. doi: 10.1155/2023/5122228. eCollection 2023.

DOI:10.1155/2023/5122228
PMID:36875495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9977546/
Abstract

Nephrotic syndrome progresses with various metabolic disturbances, such as proteinuria over 3.5 grams in 24 hours, hypoalbuminemia, and hypercoagulability. Patients usually complain about diffuse edema throughout the body, which is secondary to hypoalbuminemia. It has many primary and secondary causes. Patients may require a renal biopsy to confirm the diagnosis. Besides, many secondary causes of nephrotic syndrome should be examined and excluded. Although many vaccines were developed due to the COVID-19, many side effects are still reported because of the Pfizer-BioNTech COVID-19 vaccine (COVID-19 mRNA and BNT162b2), which is widely used in Turkey. This study examines a case of nephrotic syndrome with acute renal injury after Pfizer-BioNTech vaccine.

摘要

肾病综合征会伴随各种代谢紊乱而进展,如24小时蛋白尿超过3.5克、低白蛋白血症和高凝状态。患者通常会抱怨全身弥漫性水肿,这是低白蛋白血症的继发症状。它有许多原发性和继发性病因。患者可能需要进行肾活检以确诊。此外,应检查并排除肾病综合征的许多继发性病因。尽管由于新冠疫情研发了许多疫苗,但广泛应用于土耳其的辉瑞 - 生物科技新冠疫苗(新冠mRNA疫苗和BNT162b2)仍报告了许多副作用。本研究探讨了一例接种辉瑞 - 生物科技疫苗后发生急性肾损伤的肾病综合征病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/181b/9977546/e7de314fe73b/CRIID2023-5122228.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/181b/9977546/aff049a52869/CRIID2023-5122228.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/181b/9977546/c5ffc441513b/CRIID2023-5122228.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/181b/9977546/e7de314fe73b/CRIID2023-5122228.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/181b/9977546/aff049a52869/CRIID2023-5122228.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/181b/9977546/c5ffc441513b/CRIID2023-5122228.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/181b/9977546/e7de314fe73b/CRIID2023-5122228.003.jpg

相似文献

1
Minimal Change Nephrotic Syndrome with Acute Kidney Injury after the Administration of Pfizer-BioNTech COVID-19 Vaccine.接种辉瑞-生物科技公司新冠疫苗后发生急性肾损伤的微小病变型肾病综合征
Case Rep Infect Dis. 2023 Feb 22;2023:5122228. doi: 10.1155/2023/5122228. eCollection 2023.
2
Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation?辉瑞-生物科技公司新冠疫苗接种后出现的小儿微小病变病和急性肾损伤:是因果关系还是偶然关联?
G Ital Nefrol. 2022 Dec 21;39(6):2022-vol6.
3
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.辉瑞-生物科技 COVID-19 疫苗接种后出现微小病变病。
Am J Kidney Dis. 2021 Jul;78(1):142-145. doi: 10.1053/j.ajkd.2021.03.010. Epub 2021 Apr 8.
4
Minimal Change Disease After First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Review of Minimal Change Disease Related to COVID-19 Vaccine.首剂辉瑞 - 生物科技公司新冠疫苗接种后发生的微小病变肾病:一例病例报告及与新冠疫苗相关的微小病变肾病综述
Can J Kidney Health Dis. 2021 Nov 15;8:20543581211058271. doi: 10.1177/20543581211058271. eCollection 2021.
5
Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.贝鲁特大学社区报告的辉瑞/生物新技术(BNT162b2) COVID-19 疫苗的副作用。
BMC Infect Dis. 2023 Jan 5;23(1):5. doi: 10.1186/s12879-022-07974-3.
6
New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.辉瑞-生物科技公司的 SARS-CoV-2 疫苗接种后新发小儿肾病综合征:一例病例报告及文献综述
CEN Case Rep. 2022 May;11(2):242-246. doi: 10.1007/s13730-021-00656-0. Epub 2021 Nov 15.
7
Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.辉瑞-生物科技 COVID-19 疫苗接种后出现微小病变病的肾病综合征:两例报告。
BMJ Case Rep. 2022 Mar 4;15(3):e244638. doi: 10.1136/bcr-2021-244638.
8
Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination.辉瑞-BioNTech新冠疫苗接种后不久出现的微小病变病。
Clin Kidney J. 2021 Aug 26;14(12):2606-2607. doi: 10.1093/ckj/sfab156. eCollection 2021 Dec.
9
Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia.沙特阿拉伯12至18岁儿童接种辉瑞-BioNTech新冠mRNA疫苗的副作用
Vaccines (Basel). 2021 Nov 9;9(11):1297. doi: 10.3390/vaccines9111297.
10
Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine.广泛性丘疹水疱疹作为辉瑞-生物科技公司新冠疫苗的一种副作用
Cureus. 2022 Feb 20;14(2):e22414. doi: 10.7759/cureus.22414. eCollection 2022 Feb.

引用本文的文献

1
Two adolescents with frequently relapsing nephrotic syndrome newly diagnosed after SARS-CoV-2 vaccination: case report and literature review.两例在接种新型冠状病毒疫苗后新诊断出的频繁复发肾病综合征青少年病例报告及文献综述
CEN Case Rep. 2025 Jun;14(3):461-467. doi: 10.1007/s13730-025-00967-6. Epub 2025 Feb 17.

本文引用的文献

1
Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine.第二剂mRNA SARS-CoV-2新冠疫苗接种后发生微小病变病三例报告
Kidney Int Rep. 2021 Sep;6(9):2523-2524. doi: 10.1016/j.ekir.2021.07.017. Epub 2021 Jul 27.
2
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans.人类接种疫苗预防 COVID-19 的免疫机制。
Nat Rev Immunol. 2021 Aug;21(8):475-484. doi: 10.1038/s41577-021-00578-z. Epub 2021 Jul 1.
3
Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
辉瑞-生物科技公司新冠疫苗接种后微小病变病复发
Am J Kidney Dis. 2021 Sep;78(3):469-470. doi: 10.1053/j.ajkd.2021.05.006. Epub 2021 May 21.
4
Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine.辉瑞-生物科技公司新冠疫苗接种后出现的微小病变性肾病和急性肾损伤。
Kidney Int. 2021 Aug;100(2):461-463. doi: 10.1016/j.kint.2021.04.035. Epub 2021 May 15.
5
An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.辉瑞-BioNTech新冠疫苗接种后发生的又一例微小病变病病例。
Am J Kidney Dis. 2021 Aug;78(2):312. doi: 10.1053/j.ajkd.2021.05.003. Epub 2021 May 13.
6
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.辉瑞-生物科技 COVID-19 疫苗接种后出现微小病变病。
Am J Kidney Dis. 2021 Jul;78(1):142-145. doi: 10.1053/j.ajkd.2021.03.010. Epub 2021 Apr 8.
7
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.免疫实践咨询委员会关于使用辉瑞-BioNTech COVID-19 疫苗的临时建议-美国,2020 年 12 月。
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1922-1924. doi: 10.15585/mmwr.mm6950e2.
8
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
9
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
10
The treatment of minimal change disease in adults.成人微小病变病的治疗。
J Am Soc Nephrol. 2013 Apr;24(5):702-11. doi: 10.1681/ASN.2012070734. Epub 2013 Feb 21.